SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-18-009475
Filing Date
2018-09-17
Accepted
2018-09-17 16:46:13
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1894474
2 filename2.htm EX-10.11 620810
3 GRAPHIC g669557dsp141.jpg GRAPHIC 8796
4 GRAPHIC g669557dsp141a.jpg GRAPHIC 12986
5 GRAPHIC g669557g05t30.jpg GRAPHIC 148095
6 GRAPHIC g669557g22b30.jpg GRAPHIC 90793
7 GRAPHIC g669557g22e79.jpg GRAPHIC 79492
8 GRAPHIC g669557g31g64.jpg GRAPHIC 46377
9 GRAPHIC g669557g37n50.jpg GRAPHIC 98388
10 GRAPHIC g669557g39h59.jpg GRAPHIC 61351
11 GRAPHIC g669557g47y30.jpg GRAPHIC 79851
12 GRAPHIC g669557g61x40.jpg GRAPHIC 11999
13 GRAPHIC g669557g63g73.jpg GRAPHIC 122121
14 GRAPHIC g669557g76k16.jpg GRAPHIC 76509
15 GRAPHIC g669557g82y45.jpg GRAPHIC 24891
  Complete submission text file 0000950123-18-009475.txt   3704280
Mailing Address 4020 AERIAL CENTER PARKWAY SUITE 101 MORRISVILLE NC 27560
Business Address 4020 AERIAL CENTER PARKWAY SUITE 101 MORRISVILLE NC 27560 919-535-8861
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02191 | Film No.: 181073898
SIC: 2834 Pharmaceutical Preparations